bioRxivCancer Biology
Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells
A. E. Murmann, Q. Q. Gao, W. Putzbach, M. Patel, E. T. Bartom, C. Law, B. Bridgeman, S. Chen, K. M. McMahon, C. S. Thaxton, M. E. Peter
Abstract
Trinucleotide repeat (TNR) expansions in the genome cause a number of degenerative diseases. A prominent TNR expansion involves the triplet CAG in the huntingtin (HTT) gene responsible for Huntingtons disease (HD). Pathology is caused by protein and RNA generated from the TNR regions including small siRNA-sized repeat fragments. An inverse correlation between the length of the repeats in HTT and cancer incidence has been reported for HD patients. We now show that siRNAs based on the CAG TNR are toxic to cancer cells by targeting genes that contain long reverse complimentary TNRs in their open reading frames. Of the 60 siRNAs based on the different TNRs, the 6 members in the CAG/CUG family of related TNRs are the most toxic to both human and mouse cancer cells. siCAG/CUG TNR-based siRNAs induce cell death in vitro in all tested cancer cell lines and slow down tumor growth in a preclinical mouse model of ovarian cancer with no signs of toxicity to the mice. We propose to explore TNR-based siRNAs as a novel form of anti-cancer reagents.
- organism: human
- organism: mouse
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Huntingtin lowering reduces somatic instability at CAG-expanded loci
Sydney R. Coffey, Marissa A Andrew, … Jeffrey B. Carroll·bioRxiv·Jul 23, 2020
- Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntingtons disease pathogenesis in mice
Jillian Belgrad, Ashley Summers, … Anastasia Khvorova·bioRxiv·Jun 24, 2025
- Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
Ella W. Mathews, Sydney R. Coffey, … Jeffrey B. Carroll·Nature CommunicationsPeer-reviewed·Nov 14, 2025
- Di-valent siRNA Mediated Silencing of MSH3 Blocks Somatic Repeat Expansion in Mouse Models of Huntington's Disease
Daniel O’Reilly, Jillian Belgrad, … Anastasia Khvorova·Molecular TherapyPeer-reviewed·May 11, 2023
- mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs in vivo
Sarah E. Allen, Daniel O’Reilly, … Anastasia Khvorova·Nucleic Acid TherapeuticsPeer-reviewed·Jul 18, 2024
- VO659, a CAG repeat-targeting antisense oligonucleotide, lowers multiple neurotoxic mutant huntingtin proteins in Huntington's disease
Bas Röttgering, Rudie Weij, … Nicole A. Datson·bioRxiv·Oct 22, 2026